These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 769707)

  • 1. Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen.
    Dixon AJ; Davies J; Dormandy TL; Hamilton EB; Holt PJ; Mason RM; Thompson M; Weber JC; Zutshi DW
    Ann Rheum Dis; 1975 Oct; 34(5):416-21. PubMed ID: 769707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of D-penicillamine by multicentric double-blind comparative study in chronic rheumatoid arthritis.
    Shiokawa Y; Horiuchi Y; Honma M; Kageyama T; Okada T; Azuma T
    Arthritis Rheum; 1977; 20(8):1464-72. PubMed ID: 144507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trial comparing D-penicillamine and gold in rheumatoid arthritis. Preliminary report.
    Huskisson EC; Gibson TJ; Balme HW; Berry H; Burry HC; Grahame R; Hart FD; Henderson DR; Wojtulewski JA
    Ann Rheum Dis; 1974 Nov; 33(6):532-5. PubMed ID: 4216306
    [No Abstract]   [Full Text] [Related]  

  • 4. Controlled trial of D(-)penicillamine in severe rheumatoid arthritis.
    Lancet; 1973 Feb; 1(7798):275-80. PubMed ID: 4119168
    [No Abstract]   [Full Text] [Related]  

  • 5. Reaction to D-penicillamine in rheumatoid arthritis.
    Day AT; Golding JR
    Br Med J; 1973 Sep; 3(5880):593. PubMed ID: 4726943
    [No Abstract]   [Full Text] [Related]  

  • 6. Penicillamine for treatment of rheumatoid arthritis.
    Gordon MH; Ehrlich GE
    JAMA; 1974 Sep; 229(10):1342-3. PubMed ID: 4604882
    [No Abstract]   [Full Text] [Related]  

  • 7. Penicillamine in the treatment of rheumatoid arthritis.
    Huskisson EC; Hart FD
    Ann Rheum Dis; 1972 Sep; 31(5):402-4. PubMed ID: 5071635
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects and adverse effects in D-penicillamine therapy].
    Runge E; Tellkamp F
    Z Arztl Fortbild (Jena); 1977 Jul; 71(13):643-6. PubMed ID: 930141
    [No Abstract]   [Full Text] [Related]  

  • 9. Maintenance dose of penicillamine in rheumatoid arthritis: a comparison between a standard and a response-related flexible regimen.
    Hill HF; Hill AG; Day AT; Brown RM; Golding JR; Lyle WH
    Ann Rheum Dis; 1979 Oct; 38(5):429-33. PubMed ID: 518142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter: Penicillamine and zinc.
    Lyle WH
    Lancet; 1974 Nov; 2(7889):1140. PubMed ID: 4139431
    [No Abstract]   [Full Text] [Related]  

  • 11. Toxicity of longterm low dose D-penicillamine therapy in rheumatoid arthritis. Cooperative Systematic Studies of Rheumatic Disease Group.
    J Rheumatol; 1987 Feb; 14(1):67-73. PubMed ID: 2952797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [D-penicillamine--a current review of areas of use and dosage guidelines].
    Sörensen H
    Z Rheumatol; 1988; 47 Suppl 1():13-6. PubMed ID: 3063002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [D-penicillamine (Artamin) as basic therapeutic agent in the treatment of chronic rheumatoid arthritis].
    Tausch G; Bröll H; Eberl R
    Wien Klin Wochenschr; 1973 Jan; 85(4):59-63. PubMed ID: 4567434
    [No Abstract]   [Full Text] [Related]  

  • 14. Controlled trial of D-penicillamine in rheumatoid arthritis. Dose effect and the role of zinc.
    Mery C; Delrieu F; Ghozlan R; Saporta L; Simon F; Amor B; Menkes CJ; Delbarre F
    Scand J Rheumatol; 1976; 5(4):241-7. PubMed ID: 795022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose D-penicillamine therapy in rheumatoid arthritis. A controlled, double-blind clinical trial.
    Williams HJ; Ward JR; Reading JC; Egger MJ; Grandone JT; Samuelson CO; Furst DE; Sullivan JM; Watson MA; Guttadauria M; Cathcart ES; Kaplan SB; Halla JT; Weinstein A; Plotz PH
    Arthritis Rheum; 1983 May; 26(5):581-92. PubMed ID: 6342625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of D-penicillamine for the treatment of rheumatoid arthritis by a double blind test].
    Shiokawa Y; Horiuchi T; Honma M; Kageyama T; Okada T
    Ryumachi; 1977 Mar; 17(2):205-10. PubMed ID: 325668
    [No Abstract]   [Full Text] [Related]  

  • 17. Azathioprine versus D-penicillamine in rheumatoid arthritis patients who have been treated unsuccessfully with gold.
    Paulus HE; Williams HJ; Ward JR; Reading JC; Egger MJ; Coleman ML; Samuelson CO; Willkens RF; Guttadauria M; Alarcón GS
    Arthritis Rheum; 1984 Jul; 27(7):721-7. PubMed ID: 6378208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penicillamine in rheumatoid disease: a long-term study.
    Day AT; Golding JR; Lee PN; Butterworth AD
    Br Med J; 1974 Feb; 1(5900):180-3. PubMed ID: 4590670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The toxicity pattern of D-penicillamine therapy. A guide to its use in rheumatoid arthritis.
    Kean WF; Dwosh IL; Anastassiades TP; Ford PM; Kelly HG
    Arthritis Rheum; 1980 Feb; 23(2):158-64. PubMed ID: 7362666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.
    Neumann VC; Grindulis KA; Hubball S; McConkey B; Wright V
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1099-102. PubMed ID: 6138116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.